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Background: Turning is a challenging mobility task requiring proper planning, coordi-
nation, and postural stability to be executed efficiently. Turn deficits can impair mobility 
and lead to falls in patients with neurodegenerative disease, such as Parkinson’s disease 
(PD). It was previously shown that the cranio-caudal sequence involved during a turn 
(i.e., motion is initiated by the head, followed by the trunk) exhibits a signature that 
can be captured using an inertial system and analyzed through the Kinematics Theory. 
The so-called cranio-caudal kinematic turn signature (CCKS) metrics derived from this 
approach could, therefore, be a promising avenue to develop and track markers to 
measure early mobility deficits.
Objective: The current study aims at exploring the discriminative validity and sensitivity 
of CCKS metrics extracted during turning tasks performed by patients with PD.
Methods: Thirty-one participants (16 asymptomatic older adults (OA): mean 
age = 69.1 ± 7.5 years old; 15 OA diagnosed with early PD ON and OFF medication, 
mean age = 65.8 ± 8.4 years old) performed repeated timed up-and–go (TUG) tasks 
while wearing a portable inertial system. CCKS metrics (maximum head to trunk angle 
reached and commanded amplitudes of the head to trunk neuromuscular system, 
estimated from a sigma-lognormal model) were extracted from kinematic data recorded 
during the turn phase of the TUG tasks. For comparison purposes, common metrics 
used to analyze the quality of a turn using inertial systems were also calculated over the 
same trials (i.e., the number of steps required to complete the turn and the turn mean 
and maximum velocities).
Results: All CCKS metrics discriminated between OA and patients (p ≤ 0.041) and were 
sensitive to change in PD medication state (p ≤ 0.033). Common metrics were also able 
to discriminate between OA and patients (p < 0.014), but they were unable to capture 
the change in medication state this early in the disease (p ≥ 0.173).
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Conclusion: The enhanced sensitivity to change of the proposed CCKS metrics 
suggests a potential use of these metrics for mobility impairments identification and 
fluctuation assessment, even in the early stages of the disease.
Keywords: turn, deficit, signature, inertial motion capture, inertial measurement unit, AHRS, Parkinson’s disease, 
sigma-lognormal
INTRODUCTION
Idiopathic Parkinson’s disease (PD) is a progressive neurode-
generative disease marked by the loss of neurons producing 
dopamine. Symptoms of PD include tremor, muscle rigidity, pos-
tural instability, akinesia (lack of movement), and bradykinesia 
(slowness of movement) (1). The ability of individuals with PD to 
move around their environment and execute functional activities 
of daily living is, therefore, jeopardized by the symptoms associ-
ated with the disease. As a result, impaired mobility is recognized 
as a major cause of disability for patients, affecting their quality 
of life (2, 3). Mobility deficits also contribute to the occurrence 
of adverse events such as falls. Falls are common events among 
patients with PD, with approximately two-thirds of them being 
fallers (4, 5). It has been shown that most falls are due to patient-
related factors (i.e., intrinsic factors) and occur mainly while turn-
ing (6). To alleviate PD symptoms and related deficits, medication 
remains the principal intervention (7). However, to be efficient, 
medication type and dosage have to be personalized according to 
the evolution of symptoms. Such personalized process requires 
precise information on the patient’s ability to function during 
daily living. Unfortunately, current clinical scales provide only a 
limited portrait of the impact of symptoms, often neglecting the 
variations with time and associated movement while exhibiting a 
limited sensitivity to change (8, 9). Our research, therefore, aims 
at developing objective indicator, also called biomarkers, enabling 
the assessment of the patients’ ability to perform mobility and 
functional activities as the disease progresses.
Mobility deficits have been traditionally studied and evalu-
ated in motion laboratory, using advanced equipment such as 
camera-based optoelectronic devices (10–13). Using such setup, 
it was shown that specific characteristics of a turn are affected 
in individuals with PD, even at early stages of the disease (14). 
Patients tend to turn slower, with an increased number of steps 
and to use different motor strategies. Among these strategies, 
the so-called cranio-caudal strategy was shown to be altered in 
patients with PD. The cranio-caudal strategy refers to a specific 
cranio-caudal sequence of motions typically exhibited during a 
turn in healthy individuals (12, 15): the motion is initiated by 
the head, followed by the trunk and the pelvis until the body’s 
reorientation process toward the new direction to pursue is 
completed. This sequence can be seen as a specific cranio-caudal 
turn signature, which concept can be defined as the specific way 
(timing, force, amplitude, velocity) a movement is performed. 
Using laboratory equipment, it was shown that patients with PD 
exhibit an increased coupling of the rotational axis during the 
turn, as assessed with a decreased maximum angle of the head 
relative to the trunk (11–13), and that they initiate the turn later 
than healthy controls (10). Although, these variables offer unique 
insights into motor coordination of PD patients during turning, 
the usability and clinical applicability of the motion-capture 
measurement approach used to obtain these variables limit their 
use as outcomes measures (16).
Over the past decade, wearable inertial systems (IS) have 
emerged as an alternative to traditional motion-capture system 
for clinical applications. IS are composed of inertial measure-
ment units (IMU) which include accelerometers, gyroscopes, 
and magnetometers to measure linear acceleration, angular 
velocity, and magnetic field, respectively. Nowadays, most IS also 
include a fusion algorithm which estimates the 3D orientation of 
the IMU, enabling the capture of motion. Recently, we proposed 
a measurement approach using measures of trunk and head 
motions captured with IS to identify cranio-caudal kinematic 
turn signature (CCKS) metrics (17). On healthy individuals, the 
approach showed a good ability to capture the turn signature and 
the metrics derived were proven to be robust to speed variations 
and reliable (17). The objectives of the present study were (i) to 
explore the ability of the CCKS turn metrics measured using 
wearable inertial systems (IS) to discriminate between healthy and 
individuals with PD, (ii) to investigate the sensitivity to change 
of CCKS turn metrics during ON and OFF medication states in 
these patients who have been recently diagnosed with PD, and 
(iii) to assess the results in comparison to traditional markers of 
turn. This manuscript first introduces the CCKS technique and 
then describes the sample and protocol used to meet the specific 
objective of the paper. Results regarding both the discriminative 
validity and the sensitivity to change of the CCKS metrics and 
the traditional turn metrics are then presented, followed by a 
discussion on the findings.
MATERIALS AND METHODS
Turn Cranio-Caudal Kinematic Signature 
from IS
Assessment of the turn cranio-caudal kinematic signature refers 
to the characterization of the axial motion of the head relative 
to the trunk during the turn. Healthy individuals initiate a turn 
with the head, followed by the trunk and then the pelvis. The turn 
cranio-caudal movement can, therefore, be divided into two main 
phases: (i) the head moves away from the trunk, initiating the 
turn task; and (ii) the trunk engages into the turn closely followed 
by the pelvis, closing the gap with the head as the body realigns 
toward the new desired direction. Assessing the signature of that 
motion enables identification of different strategies and their 
related deficits.
The proposed cranio-caudal signature analysis is a two-step 
process, as presented in Figure 1A, and detailed in Lebel et al. (17). 
FIGURE 1 | Cranio-caudal kinematics signature processing. (A) Post-processing analysis overview. Head to trunk relative orientation during the turn was computed 
and derived to obtain the associated head to trunk relative angular velocity profile. Both signals are then used for signature recognition. (B) Head to trunk angular 
profile is analyzed to determine the maximum relative angle reached during the turn. (C) Head to trunk relative angular velocity profile analysis considers the turn as 
a two-phase movement. At turn initiation, a first command is sent to the neuromuscular system (NMS) to initiate the motion of the head. Shortly after, trunk motion is 
initiated through a second command. The difference in the NMS responses to those two commands generates the observed head to trunk velocity profile. Analysis 
of this profile, therefore, derives the lognormal parameters associated with the first phase, uses the lognormal equations on these parameters to deduce the 
remaining profile and, hence, the associated phase 2 lognormal parameters. (D) Lognormal parameters are derived from specific points located on the velocity 
profile curve, which coordinates are used in combination to lognormal parameters equations.
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First, the head to trunk angular profile is evaluated to determine 
the maximum angle reached during the turn (Figure 1B). Then, a 
model based on the kinematic theory, the sigma-lognormal model, 
is used to get insights into the participant’s neuromuscular system 
(NMS) (Figure 1C). Briefly, the kinematic theory stipulates that 
the response of the NMS can be recognized from the characteris-
tics of the movement itself (18) (Figure 1D). Hence, the head to 
trunk relative angular velocity profile is analyzed with the sigma-
lognormal mathematical approach, enabling the deduction of some 
of the participant’s NMS response characteristics. Specifically, for 
each phase of the turn, the model allows to determine.
t D: the amplitude of the command sent to the NMS,
t t0: the time of occurrence of the command,
t μ: the time delay of the NMS on a logarithmic scale,
t σ: the response time of the NMS on a logarithmic scale.
Mathematical details for the derivation of the different sigma-
lognormal parameters as well as further details on the cranio-
caudal turn kinematic signature characterization method are 
available in Lebel et al. (17).
Figure  2 shows typical graph results for the cranio-caudal 
signature found in a healthy elderly individual, patient with 
PD ON medication, and the same patient OFF medication. The 
present study concentrates on differences in signature patterns 
to appraise the ability of the approach to discriminate between 
patients and healthy controls and to determine its sensitivity to 
change. Specifically, this study focusses on the variation of the 
maximum head to trunk angle and the amplitude of the NMS 
commands for both turn phases as these parameters have shown 
the highest reliability (17).
Participants
Thirty-one participants [16 asymptomatic older adults (OA) 
aged between 55 and 83 years old and 15 OA diagnosed with 
Parkinson’s disease (PD), aged between 56 and 79  years old] 
were recruited from the community in collaboration with 
Quebec Parkinson Network. A description of the sample is avail-
able in Table 1. The clinical presentation of the disease varied 
between patients, but all were at an early stage of the disease 
(Hoehn&Yahr ≤2). Participants were also screened for cognitive 
deficits using the Montreal Cognitive Assessment questionnaire 
(MoCA) and none exhibited a physical limitation or pain affect-
ing their ability to perform the tasks. The study was approved by 
TABLE 1 | Sample description.
Older adults Parkinson’s disease 
patients
n 16 15
Age 69.1 ± 7.5 years old 65.8 ± 8.4 years old
Gender 50%♀ 50%♂ 40%♀ 60%♂
Height 161.3 ± 8.4 cm 171.1 ± 8.3 cm
Weight 63.2 ± 10.1 kg 74.1 ± 18.2 kg
BMI 24.3 ± 3.2 kg/m2 25.5 ± 6.8 kg/m2
H&Y* – H&Y = 1:47%
H&Y = 2:53%
Nb years since diagnostic – 5.7 ± 4.9
Montreal Cognitive Assessment 
questionnaire
– 27 ± 3
Levodopa equivalent daily dose – 508 ± 165 mg/day
Remaining symptomsa
Tremors – 27% yes; 73% no
Rigidity – 33% yes; 67% no
Bradykinesia – 7% yes; 93% no
All values are reported as mean and SD unless otherwise stated.
aFrequencies, under medication (ON).
FIGURE 2 | Cranio-caudal kinematic turn signature typical results. Example of signature patterns for a healthy elderly (left panels), a Parkinson’s disease (PD) patient 
on medication (middle panels) and that same PD patient off medication (right panels). The top panels show the variation in relative orientation of the head to the 
trunk during the turn. The maximum head to trunk angle (H2Tmax) is derived from it as a metric. The bottom panels illustrate the relative angular velocity profile (solid 
line) along with the estimated profile obtained with the sigma-lognormal model analysis (dotted line). Parameters of the sigma-lognormal are shown as inserts.
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the Centre de Recherche de l’Institut Universitaire de Gériatrie 
de Montréal ethics board and written consent were obtained for 
all participants.
Experimental Protocol
Participants performed repeated 10 m timed up-and-go (TUG) 
trials (Figure 3A) while outfitted with the IGS-180 suit (Synertial 
Ltd., UK) which contains 17 inertial modules (OS3D, Inertial 
Labs, USA) enabling full-body kinematics to be captured. 
Inertial modules positioned on the head and the trunk provided 
the orientation of both segments during the task (Figure 3B), 
allowing the computation of the relative orientation of the head 
to the trunk and the relative angular velocity profile required for 
cranio-caudal signature assessment. OA participants performed 
repeated 10 m TUG trials at varying pace (preferred vs fast pace) 
while patients performed repeated 10 m TUG trials at preferred 
speed both in their OFF and ON states. OFF state was defined 
as a minimum delay of 10 h since their last medication (PDoff) 
while ON state corresponded to a minimum delay of 45  min 
after medication intake, when motor symptoms disappeared 
or were greatly reduced (PDon), as confirmed by the patients 
themselves.
Each trial was manually segmented using a set of criteria 
defined in Lebel et al. (17) to isolate the turn phase. Briefly, the 
initial misalignment of the head–trunk–pelvis axis was visually 
identified. The point in time where the previous gait cycle began 
(i.e., heel strike) was defined as the beginning of the turn. Then, 
TABLE 2 | Turn cranio-caudal signature metrics.
Metric Description
H2Tmax Maximal head to trunk angle reached during turn
D1, D2 Amplitude of the commands for phases 1 and 2 of turn
t01, t02 Time occurrence of the commands (phases 1 and 2)
t t1 2, Time delay of the system impulse response (phases 1 and 2)
s1, s2 Neuromuscular system response time (phases 1 and 2)
FIGURE 3 | Experimental protocol. (A) timed up-and-go schematic. Participant was initially seated on a chair. Upon signal, the participant stood-up, walked up to 
the 10 m mark, turned, and came back to his initial position, on the chair. The turn phase was manually segmented in post-processing. (B) Participants were 
equipped with a suit comprised of 17 AHRS. Orientation data from the sensors placed on the head and the trunk were further processed for cranio-caudal signature 
analysis.
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signed-rank test. All statistical analysis considered a significance 
level of 0.05 and were conducted using SPSS (v23.0.0, IBM). Due 
to the exploratory nature of the study, no correction for multiple 
comparison was considered.
Turn Kinematics Traditional Parameters
For comparison purposes, metrics based on raw inertial signals 
found in the literature, namely the number of steps required 
to perform the turn, the mean turn velocity, and the max turn 
velocity, were also computed for each trial. The number of steps 
is obtained through analysis of the accelerometers signals from 
the IMUs located on the feet. Briefly, the technique consists in 
using the norm of the accelerometer signal on which is applied an 
aggressive high-pass filter to remove most of the signal’s content, 
leaving only the impacts on the floor. The location of these impacts 
are then found using a peak detection algorithm. Quality control 
checks were performed periodically to ensure the accuracy of the 
results. The mean and max turn velocities correspond to the mean 
and the max recorded angular velocity of the trunk, in the plane 
of rotation.
RESULTS
The study first aims at verifying the ability of the metrics to 
discriminate between healthy OA and early PD patients. The 
distribution of the cranio-caudal parameters value is, therefore, 
illustrated in Figure  4. Figure  4A shows that the maximum 
head to trunk angle (H2Tmax) is significantly reduced in 
patients with early PD compared to OA [healthy (median and 
inter-quartile range): 25.0° (18.1°; 30.7°), PD: 18.8° (12.5°; 
23.7°); p = 0.041]. A similar behavior is also observed with both 
phase 1 and phase 2 NMS commands [D1Healthy: 23.7 (17.1, 
28.3), D1PDoff: 16.2 (11.9, 21.5), p =  0.041; D2Healthy: 31.0 
(22.3, 36.4), D2PDoff: 13.1 (11.4, 15.5), p <  0.001], as shown 
in Figures 4B,C. A ROC curve analysis has also revealed fair 
to good areas under the curve for the three CCKS metrics 
[H2Tmax AUC: 0.724 (0.537, 0.911); D1 AUC: 0.724 (0.537, 
0.911); D2 AUC: 0.886 (0.748, 1.0)]. As far as the traditional 
the point in time where the head–trunk–pelvis realignment 
occurred was established, again through visual inspection. Heel 
strike of the following gait cycle was defined as the end of the turn. 
Segmentation was performed by the same evaluator in an attempt 
to minimize potential bias.
Signal Processing and Statistical Analysis
Cranio-caudal signature assessment follows the process described 
in Figure  1. Briefly, the relative orientation of the head to the 
trunk during the turn phase and its associated relative angular 
velocity profile are computed from the orientation signals pro-
vided by the inertial modules positioned on the head and the 
trunk of the participant. The head to trunk relative orientation 
signal is then further processed to identify the maximum angle 
reach during the turn while the relative angular velocity profile 
is analyzed through the sigma-lognormal approach, as explained 
in Section “Turn Cranio-Caudal Kinematic Signature from IS.” 
For each trial, a set of cranio-caudal metrics characterizing the 
cranio-caudal pattern is derived (Table 2). All signal processing 
is performed in Matlab v2015a (MathWorks, USA).
For each participant and condition (i.e., healthy, PDon, 
PDoff), the parameters mean was computed over the repeated 
trials. The maximum relative angle (H2Tmax) and the amplitude 
of the NMS command for both phases of the turn (D1, D2) 
were further analyzed to verify their potential to discriminate 
between populations (i.e., Healthy vs PDoff) using a Wilcoxon–
Mann–Whitney test and receiver operating characteristic (ROC) 
curves. The sensitivity to change of those same parameters was 
also evaluated (i.e., PDoff vs PDon), this time using a Wilcoxon 
FIGURE 5 | Discriminative power of traditional turn parameters. Comparison of the distribution in (A) number of steps required to perform a turn, (B) the mean turn 
velocity, and (C) the maximum turn velocity for healthy elderly vs Parkinson’s disease (PD) early stage of PD patients off medication.
FIGURE 4 | Discriminative power of cranio-caudal signature parameters. Comparison of the distribution in (A) head to trunk angle and (B,C) amplitudes of the NMS 
commands for phase 1 and 2 of the turn for healthy elderly vs patients OFF medication.
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metrics are concerned (Figure 5), the number of steps required 
to complete the turn has shown a significant increase over the 
same participants and trials [healthy: 4.0 (3.5, 4.0), PDoff: 4.5 
(4.0 5.2); p =  0.014] while the turn mean and max velocities 
have shown a significant decrease [mean turn velocity—healthy: 
1.5  rad/s (1.5,1.7), PDoff: 1.1  rad/s (1.1, 1.2), p <  0.001; max 
turn velocity—healthy: 3.9 rad/s (3.6, 4.1), PDoff: 2.9 rad/s (2.8, 
3.3), p < 0.001].
Sensitivity to change of the metrics was then verified, compar-
ing results from patients trials performed ON vs OFF medica-
tion. Analysis reveal a statistically significant improvement of 
the H2Tmax (p =  0.033) and the NMS command amplitudes 
(D1: p = 0.033, D2: p = 0.009) with medication (see Figure 6). 
However, traditional metrics did not capture a significant change 
with medication in either the number of steps required to com-
plete the turn, the mean turn velocity or the max turn velocity 
(number of steps: p = 0.462, mean turn velocity: p = 0.173, max 
turn velocity: p = 0.552), as shown in Figure 7.
DISCUSSION
A previous study performed by our team had shown the ability 
of the proposed methodology to capture the turn cranio-caudal 
signature in asymptomatic elderly (17). The current study goes 
one step further in the validation process, exploring the ability of 
the methodology to capture the turn cranio-caudal signature in 
patients with PD. General signature pattern was similar for both 
populations, but the signature characteristics were different (e.g., 
amplitude). Indeed, the three metrics derived from the signature 
(i.e., maximum head to trunk angle and amplitudes of the NMS 
commands for both phases of the turn) have shown a potential 
in discriminating between healthy individuals and patients, 
with all three parameters having significantly reduced values in 
patients. The metrics also appear to be sensitive to medication 
change, enabling to discriminate between the patients’ medica-
tion states. Indeed, CCKS metrics were, on average, higher when 
patients were ON dopaminergic therapy. In early states of PD, 
FIGURE 6 | Sensitivity to change of the cranio-caudal signature parameters. Each point on the graphs represents a participant. The graphs show the change in (A) 
head to trunk maximum angle, (B,C) amplitudes in NMS commands for phase 1 and 2 of the turn according to the medication state of the participant (i.e., on vs off 
medication). Dotted lines are the equality line, representing no change in the parameters.
FIGURE 7 | Sensitivity to change of traditional turn parameters. Comparison of (A) the number of steps required to complete a turn, (B) the mean turn velocity, and 
(C) the maximum turn velocity with the participants’ medication state. Each point on the graphs represents a participant. Dotted lines represent the line of equality, 
symbolizing no change in the parameters.
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dopamine depletion mainly occurs at the dorsal striatum level, 
affecting planning and execution of tasks. It can, therefore, be 
hypothesized that the captured variation in CCKS metrics (i.e., 
reduced values in PD compared to healthy elderly and improved 
values on dopaminergic therapy for patients) can be linked to the 
efficacy of the dopaminergic pathways. For comparison purposes, 
the number of steps taken while turning as well as the maximum 
and mean angular turn velocities were investigated for the same 
participants and trials. These more traditional metrics have also 
shown a good ability to discriminate between populations, in 
accordance with the literature (19). However, they were not able 
to differentiate between medication states, indicating a lower 
sensitivity to change. This inability of traditional metrics to dif-
ferentiate between medication states in early stages of PD was also 
noted by Curtze et al. (20). In a recent review on turn deficits in 
PD, Hulbert et al. (14) proposed to categorize turn deficits into 
axial, defined as an impaired movement of the head–trunk rota-
tional axis, and perpendicular, referring to suboptimal movement 
in the limbs. The authors suggest that axial deficits may occur 
earlier, leading to altered control in perpendicular segments. 
From this perspective, the number of steps required to perform 
a turn relates to perpendicular deficits while CCKS turn metrics 
are linked to axial deficits. Hence, the results from this study tend 
to endorse Hulbert et al.’s (14) hypothesis that axial deficit may 
8Lebel et al. Cranio-Caudal Signature for Mobility Deficit Identification
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come earlier in PD, therefore offering a more sensitive measure 
of the mobility impairments.
The signal processing technique used in the CCKS approach 
is partly based on the use of the sigma-lognormal model to 
provide insights into the NMS. Although well known to analyze 
movement in translation over a single segment, the CCKS is the 
first application to consider the model on a complex system (i.e., 
multiple segments) as well as on advanced orientation data. The 
interesting results reported in the original method paper as well 
as in the current manuscript reveal a potential for the model to be 
used in this new context. Furthermore, the methodology is based 
on inertial sensors, a technology that has the major advantage 
of being portable and relatively low-cost. Hence, the proposed 
cranio-caudal kinematic signature technique has the potential 
to be used in the clinic to enhance the accessibility to objective 
turn mobility assessment. Combined with autonomous activity 
identification and segmentation algorithms (21), the technic even 
has the potential to be used in-home to assess mobility of patients 
in their natural environment.
A limit to this study is the relatively small sample size. 
However, all patients recruited were in early stages of the 
disease to avoid extreme motor symptoms related to later 
stages of the disease. In other words, the CCKS was tested in 
the most stringent conditions since later stages of the disease 
would have probably exacerbated the motor deficits in the OFF 
condition, making it easier for our algorithms to detect them. 
Nevertheless, further validation of the metrics on a larger 
sample including a wider spectrum of symptoms is required 
to enable a clinical understanding of the variations in the 
metrics. Furthermore, the small sample size combined with the 
exploratory nature of the study has driven the statistical plan 
of analysis which does not include a correction for multiple 
comparison. Indeed, this approach was chosen in order to 
remain open-minded in the identification of the potential of 
CCKS metrics and avoid to inflate type-II error (22). Future 
studies to confirm the potential of CCKS metrics will, however, 
address this issue.
CONCLUSION
The present study reveals a potential for CCKS to assess mobility 
impairments and medication state at initial stages of the disease. 
The wearable IS used in this study combined with the sensitiv-
ity to change of the CCKS metrics opens the possibility for this 
technic to be used as markers for disease progression or to assess 
impact of medication on mobility impairments.
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